文献速递临床免疫临床微生物

梅毒螺旋体免疫检测信号强度与确认试验反应性的相关性

Correlation of Treponemal Immunoassay Signal Strength Values with Reactivity of Confirmatory Treponemal Testing.
PubMed 文献 · J Clin Microbiol · 2017-12-26

该横断面分析纳入1995份标本,评估四种自动化梅毒螺旋体免疫检测信号强度与七种确认试验反应性的相关性。结果显示信号强度值与确认试验反应性呈趋势相关(所有自动化免疫检测P<0.0001),且各自动化免疫检测存在与≥4/7项确认试验阳性对应的信号强度界值。若以95%确认水平为 adequate,这些信号强度值可替代TP-PA和FTA-ABS确认试验。

要点

  • 自动化免疫检测信号强度越高,确认试验阳性符合率越高(趋势检验均P<0.0001)。
  • BioPlex MBIA与Liaison CIA的信号界值分别对应≥99%和100%的TP-PA阳性率。
  • Advia-Centaur CIA和Trep-Sure EIA的信号界值对应至少95%的TP-PA阳性率。

核心结论

  • 自动化梅毒螺旋体免疫检测的信号强度值与确认试验反应性显著相关。
  • 假定95%确认水平足够,信号强度值可替代TP-PA和FTA-ABS确认试验。

研究设计与样本

  • 横断面分析,纳入1995份标本,其中908份(45.5%)为真阳性(≥4/7项试验阳性),1087份(54.5%)为真阴性(≥4/7项试验阴性)。
  • 评估四种自动化免疫检测(BioPlex 2200 MBIA、Liaison CIA、Advia-Centaur CIA、Trep-Sure EIA)和三种手工检测(TP-PA、FTA-ABS、Inno-LIA)。

主要发现

  • 阳性符合率从FTA-ABS的86.1%(83.7-88.2%)到Advia-Centaur CIA的99.7%(99.0-99.9%)。
  • 阴性符合率从Trep-Sure EIA的86.3%(84.1-88.2%)到TP-PA的100%(99.6-100%)。
  • 所有自动化免疫检测信号强度值与确认试验反应性均呈趋势相关(Cochran-Armitage趋势检验P<0.0001)。
  • BioPlex MBIA和Liaison CIA的信号强度界值分别与≥99%和100%的TP-PA反应性相关。
  • Advia-Centaur CIA和Trep-Sure EIA的信号强度界值与至少95%的TP-PA反应性相关;所有自动化免疫检测信号强度界值均与至少95%的FTA-ABS反应性相关。

关键数值与推荐

  • 真阳性定义:≥4/7项梅毒螺旋体试验阳性;真阴性定义:≥4/7项试验阴性。
  • 阳性符合率范围:86.1%(83.7-88.2%)至99.7%(99.0-99.9%);阴性符合率范围:86.3%(84.1-88.2%)至100%(99.6-100%)。
  • 所有自动化免疫检测信号强度与确认试验反应性的趋势检验P<0.0001。
  • BioPlex MBIA和Liaison CIA信号界值对应≥99%和100% TP-PA反应性;Advia-Centaur CIA和Trep-Sure EIA信号界值对应至少95% TP-PA反应性。
  • 所有自动化免疫检测信号界值对应至少95% FTA-ABS反应性。

临床怎么用

  • 在反向序列算法中,自动化免疫检测信号强度值可用于替代TP-PA和FTA-ABS确认试验,前提是接受95%的确认水平。
  • 高信号强度值可提示确认试验阳性可能性高,有助于减少不必要的确认试验。
  • 不同自动化免疫检测的信号强度界值不同,应使用各自验证的界值。

局限性

  • 本研究为横断面分析,未评估信号强度界值在临床结局预测中的价值。
  • 确认试验组合作为参考标准,但未与临床诊断金标准比较。
  • 标本来源和人群特征未在摘要中详述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Automated treponemal immunoassays are used for syphilis screening with the reverse-sequence algorithm; discordant results (e.g., enzyme immunoassay [EIA] reactive and reactive plasma reagin [RPR] nonreactive) are resolved with a second treponemal test. We conducted a study to determine automated immunoassay signal strength values consistently correlating with reactive confirmatory treponemal testing. We conducted a cross-sectional analysis of four automated immunoassays (BioPlex 2200 microbead immunoassay [MBIA], Liaison chemiluminescence immunoassay [CIA], Advia-Centaur CIA, and Trep-Sure EIA) and three manual assays (Treponema pallidum particle agglutination [TP-PA], fluorescent treponemal antibody absorption [FTA-ABS] test, and Inno-LIA line immunoassay). We compared signal strength values of automated immunoassays and positive and negative agreement. Among 1,995 specimens, 908 (45.5%) were true positives (≥4/7 tests reactive) and 1,087 (54.5%) were true negatives (≥4/7 tests nonreactive). Positive agreement ranged from 86.1% (83.7 to 88.2%) for FTA-ABS to 99.7% (99.0 to 99.9%) for Advia-Centaur CIA; negative agreement ranged from 86.3% (84.1 to 88.2%) for Trep-Sure EIA to 100% for TP-PA (99.6 to 100%). Increasing signal strength values correlated with increasing reactivity of confirmatory testing (P < 0.0001 for all automated immunoassays by Cochran-Armitage test for trend). All automated immunoassays had signal strength cutoffs corresponding to ≥4/7 reactive treponemal tests. BioPlex MBIA and Liaison CIA had signal strength cutoffs correlating with ≥99% and 100% TP-PA reactivity, respectively. The Advia-Centaur CIA and Trep-Sure EIA had signal strength cutoffs correlating with at least 95% TP-PA reactivity. All automated immunoassays had signal strength cutoffs correlating with at least 95% FTA-ABS reactivity. Assuming that a 95% level of confirmation is adequate, these signal strength values can be used in lieu of confirmatory testing with TP-PA and FTA-ABS.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Fakile YF, Jost H, Hoover KW, et al. Correlation of Treponemal Immunoassay Signal Strength Values with Reactivity of Confirmatory Treponemal Testing. J Clin Microbiol. 2017. PMID: 29046410. doi:10.1128/JCM.01165-17

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。